- Home/In The News/Blog/2014/September
23
September2014
category:
503b CompoundingBaxter Initiates Voluntary Recall of Potassium Chloride Injection
Baxter International announced on Sept. 16, 2014 that it is voluntarily recalling one lot of Potassium Chloride Injection 10mEq per 100mL, product code 2B0826, lot P318220, NDC #0338-0709-48 distributed to the hospital/pharmacy/nurse level for the treatment of potassium deficiency. The recall is being initiated due to a labeling error on the shipping cartons in a […]
read more23
September2014
category:
503b CompoundingHospira Issues a Voluntary Nationwide Recall
Hospira initiated a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500 mL, NDC 0409-7620-03 Lot 41-046-JT with an expiration date of 01NOV 2015. This action is due to one confirmed customer report of particulate in a single unit. […]
read more23
September2014
category:
503b CompoundingSun Pharmaceutical’s woes deepen as US arm Taro recalls Warfarin from markets
MUMBAI: Sun Pharma’s recall worries continue with its American subsidiary Taro recalling its leading blood clot drug from the market after the USFDA found that the product did not meet its quality norms. Taro has recalled Warfarin Sodium after the USFDA faulted its poor quality. This is the third such recall for Sun which agreed to buy troubled fellow drug maker Ranbaxy in […]
read more